Feb 5 2010
Epocrates,
Inc., today announced its top-ranked clinical reference application
for the iPhone® and iPod® touch devices will be customized for the new
iPad™ computer tablet. The iPad is already receiving a warm reception
from the healthcare industry with nearly 20 percent of clinicians
expressing plans to purchase in an Epocrates survey conducted days after
the Apple announcement.
“We are continuing to explore the
advanced capabilities of the iPad and ways it can help Epocrates address
the evolving healthcare technology needs.”
“By optimizing our software for the iPad, we are capitalizing on the
larger screen real estate and interactivity provided by this
sophisticated device. We are committed to providing the most productive
experience at the point of care, keeping physicians informed and focused
on the patient rather than searching for answers,” said Rose Crane,
chief executive officer of Epocrates. “We are continuing to explore the
advanced capabilities of the iPad and ways it can help Epocrates address
the evolving healthcare technology needs.”
In addition to announcing its engineers are using Apple’s SDK to
optimize Epocrates’ offerings for the iPad, Epocrates surveyed more than
350 clinicians to gauge their interest in the new tablet. Findings
include:
-
Nine percent of survey respondents plan to buy the iPad when it was
immediately available,
-
Another 13 percent plan to buy it within the year,
-
Thirty-eight percent of respondents expressed interest in the iPad
with the request of more information to solidify their purchase
decision.
Epocrates®, the first medical application available using the iPhone
SDK, was quickly adopted by medical professionals across the nation.
Today, as the most popular medical program in the Apple app store, more
than one in five physicians are actively using Epocrates on their iPhone
or iPod touch. The majority of Epocrates’ 275,000-plus physician
subscribers actively use its free or premium software on a “smartphone”
such as an iPhone, Blackberry® or Palm® device.
More than 900,000 clinicians worldwide rely on Epocrates
software at the point of care to help improve patient safety and
increase efficiencies with fast, reliable access to a host of clinical
information, such as drug dosing, health plan coverage and disease
treatment guidelines.
SOURCE Epocrates,
Inc.